Publications by authors named "Philippe Stas"

Claim this Profile
T
The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients.
Mateusz Makuch, Josine van Beek, Carla A Wijbrandts, Marja Aalbers, Philippe Stas

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical models used for immunogenicity prediction of therapeutic proteins.
Vera Brinks, Daniel Weinbuch, Matthew Baker, Yann Dean, Philippe Stas

Pharm Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunogenicity of therapeutic antibodies].
Philippe Stas, Ignace Lasters

Med Sci (Paris)· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for preclinical immunogenicity assessment of protein therapeutics.
Philippe Stas, Ignace Lasters

IDrugs· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine.
Philippe Stas, Dirk Faes, Patrick Noyens

Int J Cardiol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity screening in protein drug development.
Ivo Van Walle, Yannick Gansemans, Paul W H I Parren, Philippe Stas, Ignace Lasters

Expert Opin Biol Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis